Paclitaxel
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Paclitaxel Product Information
Paclitaxel is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Paclitaxel. The product is supplied by Clearsynth under CAT No. CS-O-30998.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Paclitaxel
CAS No.
33069-62-4
CAT No.
CS-O-30998
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C47H51NO14
Molecular Weight
853.91
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Paclitaxel is supplied with detailed characterization data compliant with regulatory guideline. Paclitaxel can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Paclitaxel.
Overview
" An antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi’s sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy."
Synonyms
Paclitaxel
Application Notes
" An antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi’s sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.